<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">17668182</PMID>
      <DateCompleted>
        <Year>2008</Year>
        <Month>05</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0342-4642</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>33</Volume>
            <Issue>12</Issue>
            <PubDate>
              <Year>2007</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Intensive care medicine</Title>
          <ISOAbbreviation>Intensive Care Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Imipramine reverses the depressive symptoms in sepsis survivor rats.</ArticleTitle>
        <Pagination>
          <StartPage>2165</StartPage>
          <EndPage>2167</EndPage>
          <MedlinePgn>2165-7</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the antidepressant effect of imipramine on depressive symptoms observed in sepsis survivors rats.</AbstractText>
          <AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Prospective, controlled experiment in an animal basic science laboratory.</AbstractText>
          <AbstractText Label="SUBJECTS" NlmCategory="METHODS">Male Wistar rats weighing 300-350 g.</AbstractText>
          <AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">The rats underwent cecal ligation and perforation (CLP; sepsis group) with "basic support" (saline at 50 ml/kg immediately and 12 h after CLP plus ceftriaxone at 30 mg/kg and clindamycin at 25 mg/kg 6, 12, and 18 h after CLP) or sham-operated (control group). After 10 days of recovery rats received intraperitoneal injections of imipramine 10 mg/kg or saline and were subjected to the forced swimming test.</AbstractText>
          <AbstractText Label="MEASUREMENTS AND RESULTS" NlmCategory="RESULTS">The observed increase in the immobility time in the forced swimming test in animals subjected to CLP, as a parameter of depressive behavior, was reversed by imipramine.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The depressive symptoms evaluated by forced swimming test had been reversed after imipramine administration. Our data provide evidence that CLP-induced depressive symptoms are sensitive to antidepressants.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tuon</LastName>
            <ForeName>Lisiane</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratório de Neurociências, Programa de Pós-Graduação Ciências da Saúde, Universidade do Extremo Sul Catarinense, 88806-000 Criciúma, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Comim</LastName>
            <ForeName>Clarissa M</ForeName>
            <Initials>CM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Antunes</LastName>
            <ForeName>Moises M</ForeName>
            <Initials>MM</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Constantino</LastName>
            <ForeName>Larissa S</ForeName>
            <Initials>LS</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Machado</LastName>
            <ForeName>Roberta A</ForeName>
            <Initials>RA</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izquierdo</LastName>
            <ForeName>Ivan</ForeName>
            <Initials>I</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Quevedo</LastName>
            <ForeName>João</ForeName>
            <Initials>J</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dal-Pizzol</LastName>
            <ForeName>Felipe</ForeName>
            <Initials>F</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2007</Year>
          <Month>08</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Intensive Care Med</MedlineTA>
        <NlmUniqueID>7704851</NlmUniqueID>
        <ISSNLinking>0342-4642</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000929">Antidepressive Agents, Tricyclic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>OGG85SX4E4</RegistryNumber>
          <NameOfSubstance UI="D007099">Imipramine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000929" MajorTopicYN="N">Antidepressive Agents, Tricyclic</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007099" MajorTopicYN="N">Imipramine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName>
          <QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2007</Year>
          <Month>4</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2007</Year>
          <Month>7</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2007</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2008</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2007</Year>
          <Month>8</Month>
          <Day>2</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">17668182</ArticleId>
        <ArticleId IdType="doi">10.1007/s00134-007-0804-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Intensive Care Med. 2003 Oct;29(10):1782-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12783160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neuropharmacology. 2005 Dec;49(7):1042-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16040063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braz J Med Biol Res. 2007 Jun;40(6):831-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17581683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crit Care Med. 2004 Feb;32(2):342-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14758146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crit Care. 2004 Apr;8(2):R91-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15025783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Learn Mem. 2000 Sep-Oct;7(5):333-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11040265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psychopharmacology (Berl). 2001 Jan;153(3):393-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11271413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biomedicine. 1979 Jul;30(3):139-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">573643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neurosci Biobehav Rev. 2005;29(4-5):547-69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15893822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crit Care Med. 2005 Jan;33(1):221-3; discussion 262-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15644673</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
